Home NDC 59762-2058-1 Sildenafil
Product NDC 59762-2058
Requested package NDC 59762-2058-1
11-digit product format 597622058
Labeler code 59762
Product ID 59762-2058_8f234077-0221-4a20-b115-23a9f061a402
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name sildenafil
Dosage form POWDER, FOR SUSPENSION
Route ORAL
Labeler Greenstone LLC
Application NDA203109
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2019-09-11
Marketing end 0000-00-00
Substance SILDENAFIL CITRATE
Active strength 10 mg/mL
Pharmacologic classes Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N203109-001 REVATIO SILDENAFIL CITRATE EQ 10MG BASE/ML FOR SUSPENSION / ORAL RLD 2012-08-30
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N203109-001 M-287 2026-01-31
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 N203109-001 REVATIO EQ 10MG BASE/ML FOR SUSPENSION / ORAL RLD 2012-08-30 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-08-01 22:54:32 2026-06 N203109-001 M-287 2026-01-31 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Revatio SILDENAFIL CITRATE Viatris Specialty LLC 3bb9363e-b28d-4019-8aae-539233dca214 2024-12-18 Warnings, Adverse reactions Exact identifier application applno (NDA): 203109 application number: NDA203109
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59762-2058-1 Sildenafil 1 in 1 CARTON POWDER, FOR SUSPENSION 1 19 59762-2058-1 Sildenafil 112 mL in 1 BOTTLE POWDER, FOR SUSPENSION 112 19
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded SILDENAFIL CITRATE ACTIVE INGREDIENT BW9B0ZE037 SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 SILDENAFIL ACTIVE MOIETY 3M7OB98Y7H SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS INACTIVE INGREDIENT L11K75P92J SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9 TRIACETIN INACTIVE INGREDIENT XHX3C3X673 SILDENAFIL (SILDENAFIL CITRATE) TABLET, FILM COATED [GREENSTONE LLC] 9
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59762-2058 SILDENAFIL TABLET, FILM COATED SILDENAFIL POWDER, FOR SUSPENSION [MYLAN PHARMACEUTICALS INC.] 19 Legacy NDC, 2 package rows 20250503_56a962e8-de00-4a97-8904-0b1bd217dd83.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 59762-2058-1 59762205801 1 BOTTLE in 1 CARTON (59762-2058-1) > 112 mL in 1 BOTTLE 1 bottle 2019-09-11 0000-00-00 No No Current